Gossamer Bio, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() AKRO
Akero Therapeutics, Inc. |
$56.19 | $4.48 B | -14.98 | 69 |
![]() ABOS
Acumen Pharmaceuticals, Inc. |
$1.12 | $69.36 M | -0.59 | 61 |
![]() HARP
Harpoon Therapeutics, Inc. |
$0.00 | $865.08 M | -15.04 | 45 |
![]() KRON
Kronos Bio, Inc. |
$0.88 | $53.65 M | -0.82 | 8 |
![]() FIXX
Homology Medicines, Inc. |
$1.56 | $3.02 M | -0.03 | 7 |
![]() BCEL
Atreca, Inc. |
$0.09 | $3.57 M | -0.04 | 90 |
![]() AMLX
Amylyx Pharmaceuticals, Inc. |
$6.33 | $566.05 M | -2.05 | 123 |
![]() BMEA
Biomea Fusion, Inc. |
$1.81 | $69.88 M | -0.53 | 79 |
![]() FDMT
4D Molecular Therapeutics, Inc. |
$3.84 | $189.47 M | -1.29 | 227 |
![]() ALEC
Alector, Inc. |
$1.48 | $147.99 M | -1.17 | 175 |
![]() PASG
Passage Bio, Inc. |
$0.33 | $20.08 M | -0.32 | 60 |
![]() BDTX
Black Diamond Therapeutics, Inc. |
$2.35 | $134.20 M | 39.33 | 24 |
![]() STOK
Stoke Therapeutics, Inc. |
$11.63 | $643.97 M | 14.38 | 128 |
![]() INZY
Inozyme Pharma, Inc. |
$3.99 | $258.25 M | -2.38 | 67 |
![]() NVCT
Nuvectis Pharma, Inc. |
$7.55 | $161.30 M | -6.83 | 13 |
![]() REPL
Replimune Group, Inc. |
$9.33 | $729.24 M | -3.08 | 479 |
![]() XFOR
X4 Pharmaceuticals, Inc. |
$1.83 | $12.21 M | 1 | 143 |
![]() LYRA
Lyra Therapeutics, Inc. |
$9.11 | $16.31 M | -0.2 | 30 |
![]() TERN
Terns Pharmaceuticals, Inc. |
$3.83 | $355.03 M | -3.76 | 59 |
![]() TCRR
TCR2 Therapeutics Inc. |
$0.00 | $58.11 M | -0.35 | 58 |